New combination vaccines still need a boost

Archives of Disease in Childhood

Volumn 92, Issue 1, 2007, Pages 1-2

  Pollard, A J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MENINGOCOCCUS VACCINE; PEDIACEL; PENTACEL; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CRYING; DISEASE TRANSMISSION; DRUG CONJUGATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEBRILE CONVULSION; HUMAN; HYPOTONIC HYPORESPONSIVE EPISODE; IMMUNE RESPONSE; IMMUNOGENICITY; PERTUSSIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; MALE; MENINGOCOCCAL VACCINES; PERTUSSIS VACCINE; VACCINES, COMBINED;

EID: 33846350634     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2006.106724     Document Type: Review

References (17)

1. Kitchin N, Southern J, Morris R, et al. A randomised controlled study of the reactogenicity of an acellular pertussis-containing pentavalent infant vaccine compared to a quadrivalent whole cell pertussis-containing vaccine and oral poliomyelitis vaccine, when given concurrently with meningococcal group C conjugate vaccine to healthy UK infants at 2, 3 and 4 months of age. Vaccine 2006;24:3964-70.
2. Le Saux N, Barrowman NJ, Moore DL, et al. Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT. Pediatrics 2003;112:e348.
3. Pichichero ME, Casey JR. Acellular pertussis vaccines for adolescents. Pediatr Infect Dis J 2005;24(Suppl):S117-26.
4. Tinnion ON, Hanlon M. Acellular vaccines for preventing whooping cough in children. Cochrane Database Syst Rev 2000;(2):CD001478.
5. Jefferson T, Rudin M, DiPietrantonj C. Systematic review of the effects of pertussis vaccines in children. Vaccine 2003;21:2003- 14.
6. Olin P, Rasmussen F, Gustafsson L, et al. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet 1997;350:1569-77.
7. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acelluiar vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 1996;334:341-8.
8. American Academy of Pediatrics. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics 2006;117:965-78.
9. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006;367:1926-36.
10. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985-9.
11. Eskola J, Ward J, Dagan R, et al. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 1999;354:2063-8.
12. McVernon J, Andrews N, Slack MP, et al. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 2003;361:1521-3.
13. Kitchin N, Southern J, Morris R, et al. Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Hib vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age. Arch Dis Child 2007;92:11-16.
14. Buttery JP, Riddell A, McVernon J, et al. Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial. JAMA 2005;293:1751-8.
15. Halperin SA, McDonald J, Samson L, et al. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus- acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomizea double-blind study. Clin Invest Med 2002;25:243-51.
16. Trotter CL, Andrews NJ, Kaczmarski EB, et al. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004;364:365-7.
17. Snape MD, Pollard AJ. Meningococcal polysaccharide-protein conjugate vaccines. Lancet Infect Dis 2005;5:21-30.